Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Contraceptive Agents, Male | 3 | 2024 | 26 | 0.600 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2024 | 524 | 0.520 |
Why?
|
| Small Molecule Libraries | 4 | 2024 | 117 | 0.500 |
Why?
|
| Drug Discovery | 4 | 2024 | 170 | 0.450 |
Why?
|
| Nuclear Proteins | 2 | 2022 | 1268 | 0.240 |
Why?
|
| Activin Receptors, Type I | 1 | 2024 | 33 | 0.240 |
Why?
|
| Contraception | 1 | 2024 | 58 | 0.220 |
Why?
|
| beta-Lactamase Inhibitors | 1 | 2023 | 55 | 0.210 |
Why?
|
| Protease Inhibitors | 1 | 2021 | 93 | 0.180 |
Why?
|
| Azepines | 1 | 2021 | 61 | 0.180 |
Why?
|
| Triazoles | 1 | 2021 | 138 | 0.170 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2022 | 303 | 0.170 |
Why?
|
| DNA | 4 | 2024 | 1594 | 0.150 |
Why?
|
| Structure-Activity Relationship | 3 | 2024 | 569 | 0.140 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 645 | 0.140 |
Why?
|
| Antineoplastic Agents | 1 | 2022 | 1663 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2023 | 2398 | 0.100 |
Why?
|
| Transcription Factors | 1 | 2021 | 2585 | 0.090 |
Why?
|
| Testis | 2 | 2024 | 412 | 0.090 |
Why?
|
| Activin Receptors, Type II | 1 | 2024 | 30 | 0.060 |
Why?
|
| Blood-Testis Barrier | 1 | 2024 | 11 | 0.060 |
Why?
|
| Receptors, Eph Family | 1 | 2024 | 21 | 0.060 |
Why?
|
| Receptor, EphA2 | 1 | 2024 | 26 | 0.060 |
Why?
|
| beta-Lactams | 1 | 2023 | 50 | 0.060 |
Why?
|
| Penicillins | 1 | 2023 | 154 | 0.050 |
Why?
|
| beta-Lactamases | 1 | 2023 | 192 | 0.050 |
Why?
|
| Molecular Conformation | 1 | 2021 | 100 | 0.050 |
Why?
|
| Quantitative Structure-Activity Relationship | 1 | 2021 | 15 | 0.050 |
Why?
|
| Protein Conformation, beta-Strand | 1 | 2021 | 16 | 0.050 |
Why?
|
| Protein Conformation, alpha-Helical | 1 | 2021 | 16 | 0.050 |
Why?
|
| Endometriosis | 1 | 2024 | 185 | 0.050 |
Why?
|
| Protein Domains | 1 | 2022 | 232 | 0.050 |
Why?
|
| Molecular Structure | 1 | 2021 | 284 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2023 | 782 | 0.040 |
Why?
|
| Genetic Engineering | 1 | 2021 | 161 | 0.040 |
Why?
|
| Cell Movement | 1 | 2024 | 831 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2021 | 138 | 0.040 |
Why?
|
| Molecular Docking Simulation | 1 | 2021 | 111 | 0.040 |
Why?
|
| High-Throughput Screening Assays | 1 | 2021 | 96 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2021 | 619 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2021 | 356 | 0.040 |
Why?
|
| Ligands | 1 | 2021 | 533 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2021 | 892 | 0.040 |
Why?
|
| Virus Replication | 1 | 2021 | 602 | 0.040 |
Why?
|
| Binding Sites | 1 | 2021 | 1291 | 0.040 |
Why?
|
| Models, Molecular | 1 | 2021 | 1069 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1689 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 1385 | 0.040 |
Why?
|
| Humans | 6 | 2024 | 123259 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2021 | 939 | 0.030 |
Why?
|
| Animals | 3 | 2024 | 33850 | 0.030 |
Why?
|
| Protein Binding | 1 | 2021 | 1741 | 0.030 |
Why?
|
| Gene Expression | 1 | 2021 | 1566 | 0.030 |
Why?
|
| Mice | 2 | 2024 | 17556 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 3044 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2021 | 982 | 0.030 |
Why?
|
| Male | 3 | 2024 | 60334 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2024 | 4497 | 0.020 |
Why?
|
| Female | 1 | 2024 | 65617 | 0.010 |
Why?
|